The oral typhoid vaccine market has witnessed significant growth in recent years owing to the rising prevalence of typhoid fever across the globe. Oral typhoid vaccines are easy to administer, not invasive, and approved for use in children above 6 months of age and adults. Typhoid still remains a serious public health problem, with an estimated 11-20 million new cases every year globally. Oral typhoid vaccines provide long-term protection against the disease and are considered a suitable option for mass immunization programs in endemic regions.

The oral typhoid vaccine market size is expected to reach US$ 285.6 Mn by 2030, from US$ 126.8 Mn in 2023, at a compound annual growth rate (CAGR) of 12.3% during the forecast period.

Key Takeaways

Key players operating in the oral typhoid vaccine market are Janssen Global Services, LLC, EMERGENT, Berna Biotech AG, Daewoong Pharmaceutical, and Bavarian Nordic. Janssen Global Services, LLC dominates the market with its oral live attenuated typhoid vaccine brand Vivotif.

Some of the key Oral Typhoid Vaccine Market Size include strategic partnerships between vaccine manufacturers and governments of endemic countries for large scale immunization programs. There is also a scope for expanding vaccine production facilities to cater to the rising global demand.

Technological advancements are leading to the development of newer generation oral typhoid vaccines with improved efficacy and longer lasting immunity. Researchers are exploring epitope-based vaccine designs and approaches like prime-boost strategies to enhance protective immune responses.

Market drivers

Growing immunization programs in Asia Pacific and Latin American countries: Several Asian and Latin American nations continue to report a high burden of typhoid and have ongoing national level typhoid conjugate vaccination programs. This is expected to majorly drive the demand for oral typhoid vaccines.

Increasing research on newer vaccine formulations: Extensive research towards the development of improvement oral typhoid vaccine candidates with longer lasting protection is anticipated to boost market growth over the forecast period.

Get More Insights on- Oral Typhoid Vaccine Market